Single-cell RNA sequencing analysis reveals the role of TXNDC5 in keloid formation

Objective: Thioredoxin domain-containing protein 5 (TXNDC5) is associated with fibrosis in a variety of organs, but its mechanism of action in keloid is unclear. In this study, we aimed to investigate the mechanism of TXNDC5 in keloid. Material and Methods: Single-cell RNA sequencing data of keloid and normal scar samples obtained from public databases were normalized and clustered using the Seurat package. Pathway enrich analysis was conducted using biological process enrichment analysis and Gene Set Enrichment Analysis (GSEA). In addition, TXNDC5 expression and its effects on migration and invasion of keloid fibroblasts (KFs) were validated based on cell function experiments. Results: A total of five cell types were obtained. The KF clusters were further clustered into two fibroblast subtypes (Fibroblast cells 1 and Fibroblast cells 2). Biological process enrichment analysis showed that transforming growth factor beta (TGF-(3) signaling pathway was enriched in the two fibroblast subtypes. GSEA analysis demonstrated that genes in TGF-(3 signaling pathway were mainly enriched in Fibroblast cells 1, and that genes involved in cell proliferation, migration, and the TGF-(3 signaling pathway were all high- expressed in fibroblast cells 1. TXND C5 was positively correlated with fibroblast proliferation, migration and TGF-(3 signaling pathway, and AUCell score. The cellular experiment confirmed that the messenger RNA and protein levels of TXND C5 and TGF-(31 were high-expressed in KFs cells (P<0.001), and that knockdown of TXND C5 downregulated TGF-(31 expression and inhibited migration and invasion of KFs (P<0.0001). Conclusion: Our study indicated that TGF-(3 signaling pathway was enriched in fibroblast cells, and TXND C5 was positively correlated with proliferation, migration, and TGF-(3 signaling pathway. Cellular experiment demonstrated that knocking down TXND C5 downregulated TGF-(3 1 expression, and suppressed migration and invasion of KFs. The current discoveries provided a new therapeutic strategy for the treatment of keloid.